Literature DB >> 7287762

Effect of energy depletion on the glycosylation of a viral glycoprotein.

R Datema, R T Schwarz.   

Abstract

In energy-depleted cells the formation of mannosylphosphoryldolichol is inhibited. Glucosyl-phosphoryldolichol, di-N-acetylchitobiosyl-pyrophosphoryl-dolichol and also GDP-mannose are still present, indicating that the formation of mannosyl-phosphoryl-dolichol and hence glycosylation of proteins via the lipid-linked oligosaccharide (Glc)3(Man)9(GlcNAc)2-pyrophosphoryl-dolichol, are under metabolic control. In the energy-depleted cells the endo-beta-N-acetylglucosaminidase H-resistant, lipid-linked oligosaccharides (Man)x(GlcNAc)2-pyrophosphoryl-dolichol (X = 1 to 5) are still formed. Despite the absence of mannosyl-phosphoryl-dolichol protein glycosylation is not blocked. The influenza virus hemagglutinin is glycosylated with endo-beta-N-acetylglucosaminidase H-resistant, but not complex, oligosaccharides. These oligosaccharides can be processed to protein-linked (Man)5(GlcNAc)2 and (Man)4(GlcNAc)2, and may represent glucosylated species. However, the rate at which the hemagglutinin leaves the rough endoplasmic reticulum and, probably therefore, the rate of oligosaccharide-processing are decreased in the energy-depleted cells. Both inhibition of formation of mannosyl-phosphoryl-dolichol and of intracellular migration are reserved when the energy status is brought back to normal levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7287762

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Functional aspects of glycoprotein N-linked oligosaccharide processing by human tumours.

Authors:  C S Foster
Journal:  Br J Cancer Suppl       Date:  1990-07

2.  Glycosylation, activity and secretion of lipoprotein lipase in cultured brown adipocytes of newborn mice. Effect of tunicamycin, monensin, 1-deoxymannojirimycin and swainsonine.

Authors:  H Masuno; C J Schultz; J W Park; E J Blanchette-Mackie; C Mateo; R O Scow
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

3.  Glycogen storage disease Ib: modification of alpha 1-antitrypsin glycoprotein microheterogeneity.

Authors:  K Heyne; J Henke-Wolter
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

4.  On the role of oligosaccharide trimming in the maturation of Sindbis and influenza virus.

Authors:  R Datema; P A Romero; R Rott; R T Schwarz
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

5.  The effect of castanospermine on the oligosaccharide structures of glycoproteins from lymphoma cell lines.

Authors:  G Palamarczyk; A D Elbein
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

Review 6.  Viral glycoprotein metabolism as a target for antiviral substances.

Authors:  H D Klenk; R T Schwarz
Journal:  Antiviral Res       Date:  1982-09       Impact factor: 5.970

7.  Inhibition of glycoprotein oligosaccharide processing in vitro and in influenza-virus-infected cells by alpha-D-mannopyranosylmethyl-p-nitrophenyltriazene.

Authors:  W McDowell; A Tlusty; R Rott; J N BeMiller; J A Bohn; R W Meyers; R T Schwarz
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

8.  Inhibition of formation of complex oligosaccharides by the glucosidase inhibitor bromoconduritol.

Authors:  R Datema; P A Romero; G Legler; R T Schwarz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

9.  Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D: N-Glycan Subtypes in Host-Pathogen Interactions.

Authors:  Lisa M Parsons; Yanming An; Li Qi; Mitchell R White; Roosmarijn van der Woude; Kevan L Hartshorn; Jeffery K Taubenberger; Robert P de Vries; John F Cipollo
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

10.  Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts.

Authors:  K Panneerselvam; H H Freeze
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.